Profitability This table compares IMAC and its rivals’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets IMAC -75.40% -52.17% -34.51% IMAC Competitors -5.53% -138.28% -0.40% Valuation and Earnings This table compares IMAC and its rivals revenue, earnings per share (EPS) and valuation. Gross Revenue Net Income […]
Posted by Tristan Rich on Aug 10th, 2026
This table compares IMAC and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IMAC | -75.40% | -52.17% | -34.51% |
| IMAC Competitors | -5.53% | -138.28% | -0.40% |
This table compares IMAC and its rivals revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| IMAC | $15.22 million | -$10.54 million | -0.00 |
| IMAC Competitors | $20.41 billion | $277.67 million | -231.69 |
IMAC’s rivals have higher revenue and earnings than IMAC. IMAC is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Institutional and Insider Ownership24.3% of IMAC shares are owned by institutional investors. Comparatively, 58.0% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 10.0% of IMAC shares are owned by insiders. Comparatively, 15.2% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk and VolatilityIMAC has a beta of -0.88, suggesting that its share price is 188% less volatile than the S&P 500. Comparatively, IMAC’s rivals have a beta of 0.97, suggesting that their average share price is 3% less volatile than the S&P 500.
SummaryIMAC rivals beat IMAC on 7 of the 9 factors compared.
IMAC Company Profile
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.
BioHarvest Sciences (NASDAQ:BHST) & Solesence (NASDAQ:SLSN) Head-To-Head Comparison
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | SIFCO Industries (SIF) versus Its Competitors Critical Analysis | 0 | 4.7 | 10-08-2026 |
| 2 | Analyzing NEXON (NEXOF) & Its Competitors | 0 | 4.84 | 09-08-2026 |
| 3 | Legrand (LGRVF) versus The Competition Critical Survey | 0 | 9.04 | 10-08-2026 |
| 4 | Comparing Labrador Iron Ore Royalty (LIFZF) & Its Peers | 0 | 6.96 | 10-08-2026 |
| 5 | Critical Analysis: Alternus Clean Energy (ALCED) & Its Rivals | 0 | 8.76 | 09-08-2026 |
| 6 | Head to Head Contrast: Jewett-Cameron Trading (JCTC) and Its Competitors | 0 | 13.37 | 10-08-2026 |
| 7 | Head to Head Comparison: Honda Motor (HMC) versus Its Peers | 0 | 10.01 | 10-08-2026 |
| 8 | Analyzing Southern Banc (OTCMKTS:SRNN) & Grupo Financiero Inbursa (OTCMKTS:GPFOF) | 0 | 11.88 | 10-08-2026 |
| 9 | Contrasting Intelligent Living Application Group (NASDAQ:ILAG) & Assa Abloy (OTCMKTS:ASAZY) | 0 | 8.27 | 10-08-2026 |
| 10 | Analyzing Mettler-Toledo International (NYSE:MTD) and ImmunoPrecise Antibodies (OTCMKTS:IPATF) | 0 | 11.54 | 10-08-2026 |